Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reversibility of Acute β-Blocker Induced Bronchoconstriction
2009-016592-29Phase 4Terminated
- Sponsor
- University of Dundee
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of propranolol in asthma, sponsored by University of Dundee. Primary endpoint: Change in FEV1 after salbutamol post histamine challenge. Started Mar 2010; status: terminated.
02
Drugs
propranolol
03
Conditions
asthma
Beyond the preview
Go deeper on 2009-016592-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016592-29.